Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments Read more
iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases Read more
Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim Read more
Ferring Receives U.S. FDA Approval for REBYOTA (fecal microbiota, live-jslm) – A Novel First-in-Class Microbiota-Based Live Biotherapeutic Read more
Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer Read more
Aldeyra Therapeutics Submits New Drug Application to the FDA for Reproxalap for the Treatment of Signs and Symptoms of Dry Eye Disease Read more
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy Read more